Read More 2 minute read Biotech General Health Care News Press Releases Top Stories Troubled Biotech Company’s Investigational Cancer Drug Gets Greenlighted By FDA By Benzinga Neuro January 31, 9:38 AM This development marks a significant milestone for 23andMe, a company that has been in the spotlight for security breaches in the past. ME